NOREPINEPHRINE in 5% Dextrose Injection recall: Sterility Concern
NOREPINEPHRINE in 5% Dextrose Injection, 8 mg per 250 mL (32 mg per mL) Injection, Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC…
Why was NOREPINEPHRINE in 5% Dextrose Injection recalled?
Lack of Assurance of Sterility
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
S21409/CCR
- Product
- NOREPINEPHRINE in 5% Dextrose Injection, 8 mg per 250 mL (32 mg per mL) Injection, Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC…
- Recalling firm
- SterRx, LLC
- Quantity
- 1428 bags
- Distribution
- U.S.A. Nationwide
- Recall date
- January 5, 2022
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)